CM313
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for CM313, covering 2022-07-20 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of CM313 in Subject With IgA Nephropathy [Phase 2]